TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ELAN

Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.10$ +1.7% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELAN
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 24.0% 23.8% 28.0% 26.4% 19.3% 19.9% 21.2% 23.7% 25.5% 25.9%
– 3.2% 3.6% 5.3% 3.7% 2.8% 3.9% 2.2% 2.5% 3.7% 4.1%
– 3.2% 3.6% 5.3% 3.7% 2.8% 3.9% 2.2% 2.5% 3.7% 4.1%
– 7.8% 6.7% 7.9% 9.9% 6.1% 6.2% 6.5% 7.0% 7.0% 7.0%
– 10.8% 11.9% 11.2% 11.7% 8.9% 8.3% 9.9% 12.1% 12.5% 13.0%
– 9.2% 10.3% 10.3% 11.6% 7.4% 7.4% 6.4% – – –
– 31.8% 33.2% 33.0% 33.3% 35.2% 37.5% 38.7% 35.5% 35.0% 35.8%
– 32.4% 29.9% 27.4% 27.6% 36.1% 33.9% 31.3% 31.3% 29.2% 25.5%
– 13.2% 12.9% 42.0% 38.3% 52.1% 54.4% 52.9% 56.7% 51.7% 51.0%
– 7.6% 7.1% 10.8% 9.1% 11.7% 10.0% 11.0% 8.6% 10.4% 12.0%
– – – 0.3% 0.3% 3.1% 1.8% 2.5% 0.3% 0.3% 0.6%
– 2.8% 2.3% 2.3% 2.5% 2.8% 2.5% 2.5% 1.9% 2.3% 2.8%
– – – 27.3% 25.9% 31.5% 36.6% 35.2% 39.9% 33.9% 29.5%
– 86.8% 87.1% 58.0% 61.7% 47.9% 45.6% 47.1% 43.3% 48.3% 49.0%
– 92.4% 89.9% 0.2% 0.9% -2.7% -5.9% -6.8% -15.9% -15.5% -16.3%
– 4.4% 4.0% 3.5% 4.1% 2.5% 3.0% 3.2% 3.4% 3.9% 3.7%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?